These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 374240)

  • 21. Hypercalcaemia in "non-secretory" myeloma.
    Taylor JJ
    Haematologia (Budap); 1986; 19(4):269-73. PubMed ID: 3546006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteinuria and hemoglobin levels in patients with primary glomerular disease.
    Mähr N; Neyer U; Prischl F; Kramar R; Mayer G; Kronenberg F; Lhotta K
    Am J Kidney Dis; 2005 Sep; 46(3):424-31. PubMed ID: 16129203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Osteosclerotic myeloma].
    Muth L; Balikó Z; Tornóczky J; Szerencse P
    Orv Hetil; 1986 Nov; 127(44):2691-4. PubMed ID: 3785948
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal disease and multiple myeloma.
    Dahlberg PJ; Keimowitz RM
    Wis Med J; 1984 Jan; 83(1):20-8. PubMed ID: 6702223
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum beta 2-microglobulin in multiple myeloma. I. Relation to selected indicators, clinical stage and disease prognosis].
    Scudla V; Budíková M; Fischerová E; Raska I; Vavrdová V
    Vnitr Lek; 1991 Apr; 37(4):342-51. PubMed ID: 2053304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Myelomatosis].
    Strunge P
    Ugeskr Laeger; 1969 Jan; 131(1):9-15. PubMed ID: 5766713
    [No Abstract]   [Full Text] [Related]  

  • 27. Reply. Kastritis E. et al. Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone containing regimes and the impact of novel agents. Haematologica 2007; 92:546-9.
    Bergner R; Hoffmann M; Uppenkamp M
    Haematologica; 2008 Jan; 93(1):e18-9. PubMed ID: 18166771
    [No Abstract]   [Full Text] [Related]  

  • 28. [Laboratory heterogeneity in 4 cases of multiple myeloma].
    Sclavo Arman I
    Prensa Med Argent; 1970 Oct; 57(35):1645-8. PubMed ID: 5503123
    [No Abstract]   [Full Text] [Related]  

  • 29. Current concepts of clinical management of multiple myeloma.
    Pingali SR; Haddad RY; Saad A
    Dis Mon; 2012 Apr; 58(4):195-207. PubMed ID: 22449368
    [No Abstract]   [Full Text] [Related]  

  • 30. [Blood uric acid in myeloma].
    Caplain-Dandine F; Kahn MF; de Sèze S
    Rev Rhum Mal Osteoartic; 1977 Jan; 44(1):1-4. PubMed ID: 834952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of hypercalcemia in patients of multiple myeloma in Karachi.
    Mansoor S; Siddiqui I; Adil S; Kakapeto GN; Fatmi Z
    J Coll Physicians Surg Pak; 2005 Jul; 15(7):409-12. PubMed ID: 16197869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypercalcemia and neoplasms].
    Rossetti A; Taliani U; Pioli G; Sansoni P
    G Clin Med; 1987; 68(6-7):335-8, 340-5. PubMed ID: 2888700
    [No Abstract]   [Full Text] [Related]  

  • 33. Xanthoma disseminatum and multiple myeloma.
    Maize JC; Ahmed AR; Provost TT
    Arch Dermatol; 1974 Nov; 110(5):758-61. PubMed ID: 4420882
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hypercalcemia associated with malignant neoplastic disorders: attempt at physiopathologic interpretation. 15 cases].
    Bloch-Michel H; Aristoff H; Gorins A; Dussart N
    Rev Rhum Mal Osteoartic; 1969 Apr; 36(4):174-90. PubMed ID: 5402944
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J
    Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum ferritin and beta-2-microglobulin in multiple myeloma].
    Linkesch W; Ludwig H
    Acta Med Austriaca; 1982; 9(5-6):227-31. PubMed ID: 6187172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple myeloma nephropathy.
    Hanicki Z; Sułowicz W
    Przegl Lek; 1985; 42(4):369-71. PubMed ID: 4048520
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prognostic factors in IgG and micromolecular multiple myeloma. Retrospective analysis of 50 consecutive cases].
    Pasqualetti P; Casale R; Colantonio D; Festuccia V; Di Lauro G; Natali G
    Minerva Med; 1987 May; 78(9):603-8. PubMed ID: 3587727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in multiple myeloma.
    Brink S; Bradshaw D; Rosenstrauch WJ; Van der Merwe AM
    S Afr Med J; 1986 Jan; 69(1):35-8. PubMed ID: 3941940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Myeloma and bone tissue: several considerations].
    Rossi P; Magliano GE; Coscia GC; Discalzi GL
    Chir Organi Mov; 1985; 70(2):141-8. PubMed ID: 4064812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.